Biogen Analysts Slash Their Forecasts After Q3 Results

Biogen Inc BIIB reported upbeat earnings for the third quarter on Wednesday.The company pisted third-quarter adjusted EPS of $4.08, down 6%, beating the consensus of$ 3.79. The company reported sales of $2.47 billion, down 3% year over on constant currency and reported basis, beating the consensus of$ 2.43 billion.Biogen raised its 2024 adjusted EPS guidance to $16.10-$ 16.60 versus prior guidance of $15.75-$ 16.25 and consensus of $16.19. Biogen continues to expect 2024 revenue to decline by a low-single-dig ...